Experienced in Ewing Sarcoma
Experienced in Ewing Sarcoma
2550 Sister Mary Columba Dr, 
Red Bluff, CA 

Overview

Mark Mogul is a Pediatrics specialist and a Hematologist in Red Bluff, California. Dr. Mogul and is rated as an Experienced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Histiocytosis, Reticulohistiocytoma, Langerhans Cell Histiocytosis, Ependymoma, and Bone Marrow Aspiration. Dr. Mogul is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 50 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 11 clinical trials in the study of Ewing Sarcoma.

Graduate Institution
State University Of New York At Buffalo School Of Medicine
Specialties
Pediatrics
Hematology
Oncology
Licenses
Pediatric Hematology-Oncology in FL
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Premera
  •  Health Options
  •  Florida Blue

Locations

2550 Sister Mary Columba Dr, Red Bluff, CA 96080

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


50 Clinical Trials

A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
Renal Tumors Classification, Biology, and Banking Study
Neuroblastoma Biology Studies
Umbrella Long-Term Follow-Up Protocol
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
View 42 Less Clinical Trials
Similar Doctors
Advanced in Ewing Sarcoma
Orthopedics | Surgical Oncology | Pediatrics
Advanced in Ewing Sarcoma
Orthopedics | Surgical Oncology | Pediatrics

Regents Of The Univ Of Ca

643 W E Ave, 
Chico, CA 
 (33.1 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robert Randall is an Orthopedics specialist and a Surgical Oncologist in Chico, California. Dr. Randall and is rated as an Advanced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Bone Tumor, Ewing Sarcoma, Fibrosarcoma, Epithelioid Sarcoma, and Hip Replacement. Dr. Randall is currently accepting new patients.

Experienced in Ewing Sarcoma
Hematology Oncology | Hematology | Oncology
Experienced in Ewing Sarcoma
Hematology Oncology | Hematology | Oncology

Docs Medical Group Inc

1825 Sonoma St, 
Redding, CA 
 (30.9 mi)
Languages Spoken:
English
Offers Telehealth

Promila Dhanuka is a Hematologist Oncology specialist and a Hematologist in Redding, California. Dr. Dhanuka and is rated as a Distinguished provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Anemia, Protein C Deficiency, and Hereditary Resistance to Anti-Vitamin K.

Experienced in Ewing Sarcoma
Hematology Oncology | Hematology | Oncology
Experienced in Ewing Sarcoma
Hematology Oncology | Hematology | Oncology

Enloe Specialty Physicians, Inc

265 Cohasset Rd, 
Chico, CA 
 (33.7 mi)
Languages Spoken:
English
Offers Telehealth

Rubens Costa-Filho is a Hematologist Oncology specialist and a Hematologist in Chico, California. Dr. Costa-Filho and is rated as a Distinguished provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Lung Cancer.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile